Comparative 6-Month Wild-Type and Delta-Variant Antibody Levels and Surrogate Neutralization for Adults Vaccinated with BNT162b2 versus mRNA-1273

Por Brian Grunau, Liam Golding, Martin A. Prusinkiewicz, Michael Asamoah-Boaheng, Richard Armour, Ana Citlali Marquez, Agatha N. Jassem, Vilte Barakauskas, Sheila F. O’Brien, Steven J. Drews, Scott Haig, Pascal M. Lavoie, David M. Goldfarb
Publicado em 2022-04-01